126 related articles for article (PubMed ID: 25853465)
1. A growing interest for intellectual property in universities.
Karytinos A; Ingham A
Pharm Pat Anal; 2015; 4(2):59-61. PubMed ID: 25853465
[No Abstract] [Full Text] [Related]
2. Technology managers do their bit for world health.
Stevens AJ
Nature; 2005 Jun; 435(7042):561. PubMed ID: 15931194
[No Abstract] [Full Text] [Related]
3. Licensing biotech intellectual property in university-industry partnerships.
Drozdoff V; Fairbairn D
Cold Spring Harb Perspect Med; 2015 Jan; 5(3):a021014. PubMed ID: 25605752
[TBL] [Abstract][Full Text] [Related]
4. John A. Fraser.
Fraser JA
Nat Rev Drug Discov; 2006 Jul; 5(7):534. PubMed ID: 16883646
[No Abstract] [Full Text] [Related]
5. Cementing links between industry and the university.
Jennings R
Nat Biotechnol; 1998 May; 16 Suppl():35-6. PubMed ID: 9591263
[No Abstract] [Full Text] [Related]
6. Science and the law. Working through the patent problem.
Walsh JP; Cohen WM; Arora A
Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
[No Abstract] [Full Text] [Related]
7. Intellectual property. University licensing and the Bayh-Dole Act.
Thursby JG; Thursby MC
Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996
[No Abstract] [Full Text] [Related]
8. Taking knowledge from bench to bank.
Horton B; Wickware P; Gershon D; Gavaghan H
Nature; 1998 Sep; 395(6700):409-14. PubMed ID: 9759734
[No Abstract] [Full Text] [Related]
9. Intellectual property rights. Public sector collaboration for agricultural IP management.
Atkinson RC; Beachy RN; Conway G; Cordova FA; Fox MA; Holbrook KA; Klessig DF; McCormick RL; McPherson PM; Rawlings HR; Rapson R; Vanderhoef LN; Wiley JD; Young CE
Science; 2003 Jul; 301(5630):174-5. PubMed ID: 12855794
[No Abstract] [Full Text] [Related]
10. Value creation and sharing among universities, biotechnology and pharma.
Edwards MG; Murray F; Yu R
Nat Biotechnol; 2003 Jun; 21(6):618-24. PubMed ID: 12776145
[No Abstract] [Full Text] [Related]
11. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
Rai AK; Reichman JH; Uhlir PF; Crossman C
Yale J Health Policy Law Ethics; 2008; 8(1):1-36. PubMed ID: 18564492
[No Abstract] [Full Text] [Related]
12. Battling infringement.
Bogen SA; Smith JM; DuPré JL
Nat Biotechnol; 2011 Jan; 29(1):19-21. PubMed ID: 21280247
[No Abstract] [Full Text] [Related]
13. Bayh-Dole: if we knew then what we know now.
Boettiger S; Bennett AB
Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
[No Abstract] [Full Text] [Related]
14. Universities shun Europe's drug initiative.
Gilbert N
Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770
[No Abstract] [Full Text] [Related]
15. Research interactions between industry and academia: a corporate perspective.
Citron P
Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
[No Abstract] [Full Text] [Related]
16. Technology transfer. Universities find too many strings attached to foundation's offer.
Holden C
Science; 2006 May; 312(5777):1127. PubMed ID: 16728608
[No Abstract] [Full Text] [Related]
17. Pharmacotherapy crisis in the spotlight--is open collaboration between academia and industry the answer?
Kaski JC
Cardiovasc Drugs Ther; 2011 Apr; 25(2):187-8. PubMed ID: 21503624
[No Abstract] [Full Text] [Related]
18. Association of University Technology Managers Asia 2013 conference.
Komatani TS
Pharm Pat Anal; 2013 Jul; 2(4):447-9. PubMed ID: 24237121
[TBL] [Abstract][Full Text] [Related]
19. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.
Janero DR
Expert Opin Drug Discov; 2012 Jun; 7(6):449-56. PubMed ID: 22540843
[TBL] [Abstract][Full Text] [Related]
20. Biobusiness on campus: commercialization of university-developed biomedical technologies.
Dueker KS
Food Drug Law J; 1997; 52(4):453-509. PubMed ID: 10346675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
